{"id":320050,"date":"2021-05-17T19:32:06","date_gmt":"2021-05-17T17:32:06","guid":{"rendered":"https:\/\/www.pcnen.com\/portal\/?p=320050"},"modified":"2021-05-17T19:32:06","modified_gmt":"2021-05-17T17:32:06","slug":"dva-nova-lijeka-protiv-korone-u-svim-bolnicama-srbije","status":"publish","type":"post","link":"https:\/\/www.pcnen.com\/portal\/2021\/05\/17\/dva-nova-lijeka-protiv-korone-u-svim-bolnicama-srbije\/","title":{"rendered":"Dva nova lijeka protiv korone u svim bolnicama Srbije"},"content":{"rendered":"<p>Od danas su u svim klini\u010dkim, klini\u010dko-bolni\u010dkim centrima i op\u0161tim bolnicama dostupna dva najnovija lijeka &#8220;Bamlanivimab&#8221; i &#8220;Regeneron&#8221; iz grupe neutrali\u0161u\u0107ih monoklonskih antitijela za lije\u010denje virusa kovid 19, navodi RFZO u saop\u0161tenju.<\/p>\n<p>Ovi ljekovi se primjenjuju u prvih deset dana od pojave simptoma i predstavljaju \u0161ansu da se infekcija zaustavi u ranoj fazi bolesti, prenosi B92.<\/p>\n<p>Lijek Bamlanivimab stigao je u Srbiju krajem marta, dok je Regeneron stigao krajem aprila \u010dime je Srbija postala jedna od rijetkih zemalja koja je nabavila oba lijeka.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ovi ljekovi se primjenjuju u prvih deset dana od pojave simptoma i predstavljaju \u0161ansu da se infekcija zaustavi u ranoj fazi bolesti,<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[14],"tags":[],"class_list":["post-320050","post","type-post","status-publish","format-standard","hentry","category-vijesti"],"_links":{"self":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/320050","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/comments?post=320050"}],"version-history":[{"count":1,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/320050\/revisions"}],"predecessor-version":[{"id":320051,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/320050\/revisions\/320051"}],"wp:attachment":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/media?parent=320050"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/categories?post=320050"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/tags?post=320050"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}